MCD to Procure 98,500 Anti-Rabies Vaccine Vials to Combat Animal Attacks
The Municipal Corporation of Delhi is procuring 98,500 anti-rabies vaccine vials to ensure timely treatment for animal attack victims.
In a major move to safeguard public health and ensure immediate medical response to animal attacks, the Municipal Corporation of Delhi (MCD) has approved the procurement of 98,500 vials of anti-rabies vaccine. This initiative aims to provide timely and critical treatment to citizens who fall victim to attacks by dogs, monkeys, cats, and other animals across the capital.
A Strategic Two-Year Plan
The procurement is part of a larger, comprehensive strategy designed to meet the city's medical requirements for the next two years. The MCD has mapped out a total requirement of 1.20 lakh vials to ensure that there is no shortage of this life-saving medicine at its healthcare facilities.
According to an official release from the office of the Chairperson of the Standing Committee, the procurement process is being executed in phases:
- Initial Phase: 21,500 vials were already purchased in May 2026 to address immediate needs.
- Current Phase: Approval has now been granted for the remaining 98,500 vials to complete the two-year quota.
Prioritizing Patient Care
Satya Sharma, Chairperson of the MCD Standing Committee, emphasized that providing prompt treatment to those injured in animal attacks is a top priority for the Corporation. She highlighted that in cases of animal bites, the window for medical intervention is narrow, making the availability of vaccines at the point of care absolutely crucial.
"Maintaining sufficient stocks of essential vaccines at healthcare institutions is crucial in such situations. The MCD has assessed the requirements of its healthcare services and prepared a procurement plan to meet the vaccine requirements for the next two years," Sharma stated.
Expanding Reach Across Delhi
The MCD operates a network of healthcare facilities dedicated to treating animal bite victims. The vaccine distribution will cover:
- 4 Major Hospitals
- 25 Health Centres
Based on data from these institutions, the Corporation has estimated an average annual requirement of approximately 60,000 vials. By securing 1.20 lakh vials for a two-year period, the MCD intends to create an uninterrupted supply chain, ensuring that patients do not face unnecessary hurdles or delays in receiving treatment.
Commitment to Better Healthcare
The Corporation has reiterated its commitment to enhancing the overall healthcare infrastructure for the citizens of Delhi. By aligning the procurement plan with the actual estimated needs of its hospitals and clinics, the MCD aims to eliminate the risk of vaccine shortages, ensuring that every patient visiting their facilities receives essential medical assistance without delay.